Anavex Life Sciences (AVXL) Competitors $6.84 +0.21 (+3.17%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends AVXL vs. BASI, ARVN, WVE, TECX, OCUL, NAMS, IMCR, NTLA, SNDX, and CNTAShould you be buying Anavex Life Sciences stock or one of its competitors? The main competitors of Anavex Life Sciences include Bioanalytical Systems (BASI), Arvinas (ARVN), Wave Life Sciences (WVE), Tectonic Therapeutic (TECX), Ocular Therapeutix (OCUL), NewAmsterdam Pharma (NAMS), Immunocore (IMCR), Intellia Therapeutics (NTLA), Syndax Pharmaceuticals (SNDX), and Centessa Pharmaceuticals (CNTA). These companies are all part of the "medical" sector. Anavex Life Sciences vs. Bioanalytical Systems Arvinas Wave Life Sciences Tectonic Therapeutic Ocular Therapeutix NewAmsterdam Pharma Immunocore Intellia Therapeutics Syndax Pharmaceuticals Centessa Pharmaceuticals Anavex Life Sciences (NASDAQ:AVXL) and Bioanalytical Systems (NASDAQ:BASI) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their community ranking, institutional ownership, valuation, earnings, profitability, analyst recommendations, dividends, media sentiment and risk. Is AVXL or BASI more profitable? Anavex Life Sciences has a net margin of 0.00% compared to Bioanalytical Systems' net margin of -7.75%. Anavex Life Sciences' return on equity of -30.64% beat Bioanalytical Systems' return on equity.Company Net Margins Return on Equity Return on Assets Anavex Life SciencesN/A -30.64% -28.23% Bioanalytical Systems -7.75%-42.74%-6.38% Do insiders and institutionals have more ownership in AVXL or BASI? 31.5% of Anavex Life Sciences shares are held by institutional investors. Comparatively, 10.6% of Bioanalytical Systems shares are held by institutional investors. 11.0% of Anavex Life Sciences shares are held by insiders. Comparatively, 11.5% of Bioanalytical Systems shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more volatility & risk, AVXL or BASI? Anavex Life Sciences has a beta of 0.61, suggesting that its share price is 39% less volatile than the S&P 500. Comparatively, Bioanalytical Systems has a beta of 1.92, suggesting that its share price is 92% more volatile than the S&P 500. Which has stronger valuation & earnings, AVXL or BASI? Bioanalytical Systems has higher revenue and earnings than Anavex Life Sciences. Anavex Life Sciences is trading at a lower price-to-earnings ratio than Bioanalytical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnavex Life SciencesN/AN/A-$47.51M-$0.50-13.67Bioanalytical Systems$60.47M0.33-$4.68M-$0.35-5.09 Does the media favor AVXL or BASI? In the previous week, Anavex Life Sciences had 5 more articles in the media than Bioanalytical Systems. MarketBeat recorded 5 mentions for Anavex Life Sciences and 0 mentions for Bioanalytical Systems. Anavex Life Sciences' average media sentiment score of 0.18 beat Bioanalytical Systems' score of 0.00 indicating that Anavex Life Sciences is being referred to more favorably in the media. Company Overall Sentiment Anavex Life Sciences Neutral Bioanalytical Systems Neutral Does the MarketBeat Community favor AVXL or BASI? Anavex Life Sciences received 300 more outperform votes than Bioanalytical Systems when rated by MarketBeat users. Likewise, 74.31% of users gave Anavex Life Sciences an outperform vote while only 38.79% of users gave Bioanalytical Systems an outperform vote. CompanyUnderperformOutperformAnavex Life SciencesOutperform Votes42874.31% Underperform Votes14825.69% Bioanalytical SystemsOutperform Votes12838.79% Underperform Votes20261.21% Do analysts rate AVXL or BASI? Anavex Life Sciences presently has a consensus target price of $40.00, indicating a potential upside of 485.22%. Given Anavex Life Sciences' higher possible upside, equities analysts clearly believe Anavex Life Sciences is more favorable than Bioanalytical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Anavex Life Sciences 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50Bioanalytical Systems 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A SummaryAnavex Life Sciences beats Bioanalytical Systems on 10 of the 17 factors compared between the two stocks. Ad Crypto Swap Profits625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here Get Anavex Life Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for AVXL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AVXL vs. The Competition Export to ExcelMetricAnavex Life SciencesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$579.58M$3.14B$5.50B$8.53BDividend YieldN/A1.77%5.13%4.14%P/E Ratio-13.6712.03116.1015.23Price / SalesN/A400.761,496.2597.74Price / CashN/A149.0039.7434.10Price / Book3.954.024.775.07Net Income-$47.51M-$42.25M$119.06M$225.46M7 Day Performance30.44%8.04%0.80%0.37%1 Month Performance20.87%8.69%5.65%3.57%1 Year Performance20.12%32.09%36.75%29.43% Anavex Life Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AVXLAnavex Life Sciences3.4845 of 5 stars$6.84+3.2%$40.00+485.2%+21.6%$579.58MN/A-13.6740News CoverageGap UpBASIBioanalytical SystemsN/A$1.71+1.8%N/A-4.8%$19.03M$60.47M-4.07397Analyst ForecastARVNArvinas2.1178 of 5 stars$25.92-3.8%$57.69+122.6%+68.3%$1.77B$93.30M-5.01445Earnings ReportAnalyst ForecastShort Interest ↓Analyst RevisionNews CoverageWVEWave Life Sciences4.9435 of 5 stars$14.45-2.5%$19.44+34.6%+160.9%$1.77B$110.50M-25.35240Analyst ForecastTECXTectonic Therapeutic3.2954 of 5 stars$38.74+6.4%$60.00+54.9%N/A$1.74BN/A-7.49120Positive NewsGap UpHigh Trading VolumeOCULOcular Therapeutix4.1857 of 5 stars$11.14+2.3%$16.57+48.8%+225.7%$1.74B$58.44M-8.25267Upcoming EarningsNAMSNewAmsterdam Pharma3.2478 of 5 stars$19.09+1.2%$33.80+77.1%+92.4%$1.70B$14.09M0.0057Upcoming EarningsIMCRImmunocore2.2449 of 5 stars$32.80+0.9%$75.17+129.2%-30.1%$1.64B$280.91M-30.37320Upcoming EarningsNTLAIntellia Therapeutics4.2672 of 5 stars$15.95+0.6%$59.13+270.7%-41.9%$1.62B$36.28M-2.91600High Trading VolumeSNDXSyndax Pharmaceuticals4.0313 of 5 stars$18.75-1.3%$35.90+91.5%+36.4%$1.59B$3.50M-5.55110Upcoming EarningsCNTACentessa Pharmaceuticals3.456 of 5 stars$15.50flat$25.17+62.4%+128.8%$1.56B$6.85M-9.9472 Related Companies and Tools Related Companies BASI Alternatives ARVN Alternatives WVE Alternatives TECX Alternatives OCUL Alternatives NAMS Alternatives IMCR Alternatives NTLA Alternatives SNDX Alternatives CNTA Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:AVXL) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredNothing can stop this gold rallyAfter what's felt like nearly a decade of disappointing gains, gold is stronger than ever and continues to hit...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Anavex Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Anavex Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
